The revised $9 billion rescissions package restores funding for the Pepfar program.

A larger role for China, perhaps, and the fraught issue of integrating HIV services into services for other diseases.

The rescissions package, a Trump Administration initiative under the Department of Government Efficiency (DOGE), aims to ...

When it comes to a clinical study to evaluate the therapeutic effect of Shivagutika treatment in patients with HIV, it was ...

The Senate is poised to vote this week on President Donald Trump's rescissions package requesting roughly $9.4 billion in ...

The administration made a deal with Senate Republicans to remove $400 million in proposed cuts to the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR).

Artificial intelligence chatbots could help with the introduction of a twice-yearly shot that can help prevent HIV, experts ...

ViiV Healthcare has announced steps to widen access to a sought-after HIV medicine in low- and middle-income countries, ...

Despite the recent approval of lenacapavir as a twice yearly PrEP, there is still a need for choice in HIV prevention, argue ...

As HIV cases continue to rise in the Philippines, especially among the youth, a new global development may offer hope in ...

The World Health Organization now recommends lenacapavir, a twice-yearly injectable HIV prevention drug, especially for high-risk groups. This endorse ...

The Ghana HIV and AIDS Network (GHANET) is taking a proactive and strategic approach to combat the nation's HIV epidemic, focusing on a demographic often overlooked in health-seeking behaviours.